UK markets open in 2 hours 25 minutes

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
47.63-0.68 (-1.41%)
At close: 04:00PM EDT
47.63 0.00 (0.00%)
After hours: 04:17PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2021
30/09/2020
30/09/2019
30/09/2018
Total revenue
249,939
138,287
87,992
168,796
16,142
Operating expenses
Research development
279,696
206,342
128,875
81,049
52,969
Selling general and administrative
129,480
80,981
52,276
26,556
19,110
Total operating expenses
409,499
287,323
181,151
107,605
72,079
Operating income or loss
-159,560
-149,036
-93,159
61,191
-55,936
Total other income/expenses net
1,038
2,070
-582.524
-
439.634
Income before tax
-153,924
-140,846
-84,551
68,148
-54,448
Income tax expense
2
2
2.4
173.553
2.4
Income from continuing operations
-153,926
-140,848
-84,553
67,975
-54,450
Net income
-153,926
-140,848
-84,553
67,975
-54,450
Net income available to common shareholders
-153,926
-140,848
-84,553
67,975
-54,450
Basic EPS
-
-1.36
-0.84
0.72
-0.65
Diluted EPS
-
-1.36
-0.84
0.69
-0.65
Basic average shares
-
103,745
100,722
93,859
83,638
Diluted average shares
-
103,745
100,722
98,608
83,638
EBITDA
-
-140,769
-87,217
65,630
-51,237